SCHEMBL30795482

SCHEMBL30795482

O=C1N[C@H](c2cncc(C#Cc3ccccc3)c2)[C@@H](c2cc(F)ccc2F)O1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 20/20 1.00
PGR P06401 1/20 1.00
KCNH2 Q12809 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4541079 1.00 GRM5 (1.00) GRM5PGRKCNH2
SCHEMBL5022150 1.00 GRM5 (1.00) GRM5PGRKCNH2
SCHEMBL4562039 0.95 GRM5 (0.90) GRM5PGRKCNH2
SCHEMBL5021955 0.93 GRM5 (0.86) GRM5PGRKCNH2
SCHEMBL4562751 0.93 GRM5 (0.86) GRM5PGRKCNH2
SCHEMBL30795600 0.93 GRM5 (0.86) GRM5PGRKCNH2
SCHEMBL5021917 0.92 GRM5 (0.85) GRM5PGRKCNH2
SCHEMBL13585312 0.92 GRM5 (0.85) GRM5PGRKCNH2
SCHEMBL4562091 0.92 GRM5 (1.00) GRM5PGRKCNH2
SCHEMBL13584690 0.92 GRM5 (0.85) GRM5PGRKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584250-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS Biohaven Therapeutics Ltd. (VG) 2025-07-16 EP disclosed
WO-2024054811-A1 COMBINATION THERAPIES INCLUDING METAL CHANNEL ACTIVATORS BIOHAVEN THERAPEUTICS LTD. (VG) 2024-03-14 WO disclosed